Cargando…
Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?
Despite enormous progress in the treatment of many malignancies, the development of cancer resistance is still an important reason for cancer chemotherapy failure. Increasing knowledge of cancers’ molecular complexity and mechanisms of their resistance to anticancer drugs, as well as extensive clini...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124695/ https://www.ncbi.nlm.nih.gov/pubmed/33946916 http://dx.doi.org/10.3390/molecules26092601 |